Clinical Trial Update: Doxorubicin vs. Trabectedin Plus Doxorubicin in Non Operable and/or Metastatic STS [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing Doxorubicin alone versus Trabectedin plus Doxorubicin in non-operable and/or metastatic soft tissue sarcoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Doxorubicin (doxorubicin)
• Trabectedin (trabectedin)

Snippet

Sponsor: Grupo Espanol de Investigacion en Sarcomas | Conditions: Sarcoma | Phase 2 | Status: TERMINATED